Associated Papers
Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants.
Ma L et al.
International Journal of Molecular Sciences, 2022
Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1.
Koh Y et al.
Journal of Virology, 2011
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors.
Ntemgwa M et al.
Antimicrobial Agents and Chemotherapy, 2007
Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors.
Gatanaga H et al.
The Journal of Biological Chemistry, 2002
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors.
Doyon L et al.
Journal of Virology, 1996
Select a paper to view details